110 related articles for article (PubMed ID: 9032540)
1. The 72nd codon change of p53 in primary renal cell carcinoma was confirmed as a polymorphism among Japanese.
Kageyama Y; Yamamura Y; Oshima H; Ikawa Y
Eur Urol; 1997; 31(1):81-5. PubMed ID: 9032540
[TBL] [Abstract][Full Text] [Related]
2. Infrequent involvement of p53 mutations and loss of heterozygosity of 17p in the tumorigenesis of renal cell carcinoma.
Uchida T; Wada C; Shitara T; Egawa S; Mashimo S; Koshiba K
J Urol; 1993 Oct; 150(4):1298-301. PubMed ID: 8103806
[TBL] [Abstract][Full Text] [Related]
3. Infrequent alteration of the DPC4 tumor suppressor gene in renal cell carcinoma.
Popović Hadzija M; Hrasćan R; Bosnar MH; Zeljko Z; Hadzija M; Cadez J; Pavelić K; Kapitanović S
Urol Res; 2004 Jun; 32(3):229-35. PubMed ID: 15107966
[TBL] [Abstract][Full Text] [Related]
4. A novel p53 mutation hotspot at codon 132 (AAG-->AGG) in human renal cancer.
Dahiya R; Deng G; Selph C; Carroll P; Presti J
Biochem Mol Biol Int; 1998 Feb; 44(2):407-15. PubMed ID: 9530523
[TBL] [Abstract][Full Text] [Related]
5. [Pilot study on mutations of p53 gene in laryngeal carcinoma].
Zhou G; Zhang X; Lui S; Lin D; Liang C; Yang X
Hua Xi Yi Ke Da Xue Xue Bao; 2001 Sep; 32(3):359-60, 434. PubMed ID: 12536563
[TBL] [Abstract][Full Text] [Related]
6. p53 tumor suppressor gene in acoustic neuromas.
Monoh K; Ishikawa K; Yasui N; Mineura K; Andoh H; Togawa K
Acta Otolaryngol Suppl; 1998; 537():11-5. PubMed ID: 9870642
[TBL] [Abstract][Full Text] [Related]
7. Chromosome 17p deletions and p53 mutations in renal cell carcinoma.
Reiter RE; Anglard P; Liu S; Gnarra JR; Linehan WM
Cancer Res; 1993 Jul; 53(13):3092-7. PubMed ID: 8319216
[TBL] [Abstract][Full Text] [Related]
8. Molecular pathology of primary and metastatic ductal pancreatic lesions: analyses of mutations and expression of the p53, mdm-2, and p21/WAF-1 genes in sporadic and familial lesions.
Ruggeri BA; Huang L; Berger D; Chang H; Klein-Szanto AJ; Goodrow T; Wood M; Obara T; Heath CW; Lynch H
Cancer; 1997 Feb; 79(4):700-16. PubMed ID: 9024708
[TBL] [Abstract][Full Text] [Related]
9. Genomic organization and chromosomal localization of the human CUL2 gene and the role of von Hippel-Lindau tumor suppressor-binding protein (CUL2 and VBP1) mutation and loss in renal-cell carcinoma development.
Clifford SC; Walsh S; Hewson K; Green EK; Brinke A; Green PM; Gianelli F; Eng C; Maher ER
Genes Chromosomes Cancer; 1999 Sep; 26(1):20-8. PubMed ID: 10441001
[TBL] [Abstract][Full Text] [Related]
10. Infrequent mutations of the WT1 gene in primary cancers of the adult urinary tract.
Kageyama Y; Yamamura Y; Oshima H; Ikawa Y
Jpn J Clin Oncol; 1995 Oct; 25(5):173-8. PubMed ID: 7474403
[TBL] [Abstract][Full Text] [Related]
11. Infrequent mutation of p53 gene in human renal cell carcinoma detected by polymerase chain reaction single-strand conformation polymorphism analysis.
Suzuki Y; Tamura G; Satodate R; Fujioka T
Jpn J Cancer Res; 1992 Mar; 83(3):233-5. PubMed ID: 1582882
[TBL] [Abstract][Full Text] [Related]
12. Detection of p53 gene alteration in renal-cell cancer by micropreparation techniques of tumor specimens.
Kuczyk MA; Serth J; Bokemeyer C; Jonassen J; Arndt H; Paeslack U; Werner M; Tan HK; Jonas U
Int J Cancer; 1995 Dec; 64(6):399-406. PubMed ID: 8550242
[TBL] [Abstract][Full Text] [Related]
13. Absence of ras mutations and low incidence of p53 mutations in renal cell carcinomas induced by ferric nitrilotriacetate.
Akiyama T; Hamazaki S; Okada S
Jpn J Cancer Res; 1995 Dec; 86(12):1143-9. PubMed ID: 8636002
[TBL] [Abstract][Full Text] [Related]
14. [Detection of mutations in exon 7 of p53 from fresh tumor samples by single-strand conformation polymorphism and direct DNA sequencing].
Zhang X; Fu Y; Liu S; Liang C
Zhonghua Er Bi Yan Hou Ke Za Zhi; 2001 Apr; 36(2):142-5. PubMed ID: 12761985
[TBL] [Abstract][Full Text] [Related]
15. Low incidence of point mutations in H-, K- and N-ras oncogenes and p53 tumor suppressor gene in renal cell carcinoma and peritoneal mesothelioma of Wistar rats induced by ferric nitrilotriacetate.
Nishiyama Y; Suwa H; Okamoto K; Fukumoto M; Hiai H; Toyokuni S
Jpn J Cancer Res; 1995 Dec; 86(12):1150-8. PubMed ID: 8636003
[TBL] [Abstract][Full Text] [Related]
16. Mutation of tumor suppressor gene p53 is frequently found in vulvar carcinoma cells.
Hietanen SH; Kurvinen K; Syrjänen K; Grénman S; Carey T; McClatchey K; Syrjänen S
Am J Obstet Gynecol; 1995 Nov; 173(5):1477-82. PubMed ID: 7503188
[TBL] [Abstract][Full Text] [Related]
17. Analysis of genetic alterations in renal cell carcinoma using the polymerase chain reaction.
Suzuki Y; Tamura G; Maesawa C; Fujioka T; Kubo T; Satodate R
Virchows Arch; 1994; 424(5):453-7. PubMed ID: 8032525
[TBL] [Abstract][Full Text] [Related]
18. Alterations of retinoblastoma, p53, p16(CDKN2), and p15 genes in human astrocytomas.
Tsuzuki T; Tsunoda S; Sakaki T; Konishi N; Hiasa Y; Nakamura M
Cancer; 1996 Jul; 78(2):287-93. PubMed ID: 8674005
[TBL] [Abstract][Full Text] [Related]
19. Infrequent alteration of p53 pathway in metastatic renal cell carcinoma.
Kawasaki T; Bilim V; Takahashi K; Tomita Y
Oncol Rep; 1999; 6(2):329-33. PubMed ID: 10022999
[TBL] [Abstract][Full Text] [Related]
20. Mutations of the p53 gene in carcinomas of the urinary system.
Suzuki Y; Tamura G
Acta Pathol Jpn; 1993 Dec; 43(12):745-50. PubMed ID: 8109252
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]